New findings from Aarhus University Hospital shed light on how 15O-water PET MPI may benefit patients with bypass surgery
New findings from Aarhus University Hospital shed light on how 15O-water PET MPI may benefit patients with bypass surgery 15O-water PET MPI may be a promising way to personalize treatment for patients with a history of bypass surgery who are still experiencing chest pain. That is the short version of the conclusion in a recent […]
Aarhus University Hospital document frequent extracardiac findings on 15O-water PET myocardial perfusion imaging
Aarhus University Hospital document frequent extracardiac findings on 15O-water PET myocardial perfusion imaging From tumors and lung cancer to rib fractures and COVID-19 infiltrates. Researchers at Aarhus University Hospital document that 15O-water PET myocardial perfusion imaging (MPI) often reveals several extracardiac findings or, in other words, findings outside of the intended scope. In their article […]
First Oncology Patient Scanned with 15O-water on MedTrace Equipment
First Oncology Patient Scanned with 15O-water on MedTrace Equipment Osaka University Hospital has dosed and scanned the first subject with 15O-water in the university’s scientific study “Evaluation of blood flow of malignant tumor using 15O-water PET”. The study utilized 15O-water from MedTrace’s automated manufacturing system (P3 MT-100). “We are very proud that we have scanned […]
MedTrace receives U.S. patent for diagnosing the human heart
MedTrace receives U.S. patent for diagnosing the human heart The U.S. Patent and Trademark Office issued a patent to MedTrace for their method of diagnosing the human heart via 15O-water PET. The patented method is the foundation of the company’s software aQuant, currently under development. Hendrik “Hans” Harms, PhD and Senior Scientist at MedTrace, and Jens […]
15O-water myocardial perfusion imaging: a practical approach to simplifying the gold standard for approved clinical use
15O-water myocardial perfusion imaging: a practical approach to simplifying the gold standard for approved clinical use Mark Lubberink, PhD, Scientific Advisor to MedTrace & Hendrik “Hans” Harms, PhD, Senior Scientist at MedTrace, are contributing to the November issue of Society of Nuclear Medicine and Molecular Imaging (SNMMI)’s Value Initiative Newsletter. Lubberink & Harms elaborate on the challenges of […]
MedTrace gathered +100 doctors and scientists of nuclear medicine for the company’s symposium on the future of 15O-water
MedTrace gathered +100 doctors and scientists of nuclear medicine for the company’s symposium on the future of 15O-water On October 17, 2022, MedTrace hosted a discussion on the future of 15O-water in conjunction with the 35th annual congress of the European Association of Nuclear Medicine in Barcelona. The event was the first symposium held by […]
MedTrace Announces First Subject Scanned in Phase 3 Clinical Trial
MedTrace Pharma Announces First Subject Scanned in the Company’s RAPID-WATER-FLOW Phase 3 Clinical Trial First Subject Scanned in RAPID-WATER-FLOW Trial at Aarhus University Hospital, Denmark Multiple Sites Involved Across the United States, Denmark, Sweden, and The Netherlands The Global Trial is Expected to Continue for 12 Months MedTrace Pharma A/S, a pharma and device company […]
MedTrace announces IND approval of RAPID-WATER phase 3 clinical trial
MedTrace Pharma announces IND approval with the initiation of RAPID-WATER phase 3 clinical trial MedTrace Pharma A/S announced today the FDA approval of the company’s Investigational New Drug (IND) application and the approval to commence the RAPID-WATER clinical trial to evaluate the use of 15O-water PET in diagnosing Coronary Artery Disease (CAD). The global trial […]
MedTrace Pharma takes step towards CE marking
MedTrace Pharma takes step towards CE marking A notified body has signed a contract to review MedTrace Pharma’s aQuant software and patient kit products with an eye to CE marking. The notified body, BSI, is based in the Netherlands. “We’re encouraged that BSI has agreed to audit our products,” says Rune Wiik Kristensen of MedTrace […]
MedTrace Installs P3 System at Sahlgrenska University Hospital
MedTrace Installs P3 System at Sahlgrenska University Hospital MedTrace Pharma A/S has signed a contract with Sahlgrenska University Hospital in Gothenburg, Sweden for the installation of a new P3 production and infusion system providing up to 1000 doses of 15O-water per year for the next five years. The Gothenburg-based hospital, one of the largest in […]